Published: 29 September 2018
Author(s): Elisa Lucchini, Renato Fanin, Nichola Cooper, Francesco Zaja

Despite the improvement in understanding its pathogenesis and the introduction of novel treatment options, the management of primary immune thrombocytopenia (ITP) still remains challenging. Considering its increased incidence with aging and prolonged life-expectancy, ITP is often diagnosed in elderly patients, a subset that deserves some special precautions. Ensure the diagnosis is a crucial step, and carefully attention must be given in excluding other causes of thrombocytopenia, especially among older people that frequently suffer from many comorbidities.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.